Results 261 to 270 of about 66,239 (358)

Reversal of Rivaroxaban-Induced Alterations on Hemostasis by Different Coagulation Factor Concentrates

, 2014
Ginés Escolar, Eduardo Arellano‐Rodrigo, Irene López-Vílchez, Patricia Molina, Juan Sanchis, Joan Carles Reverter, Xavier Carné, Joan Cid, Jaume Villalta, Dolors Tàssies, Ana M. Galán, Maribel Díaz‐Ricart   +11 more
openalex   +2 more sources

Editorial Comment: Non-Vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Atrial Fibrillation and Concomitant Mitral Stenosis: A Retrospective Observational Study. [PDF]

Acta Cardiol Sin
Liu CM, Chao TF.
europepmc   +1 more source

Response to ‘Re: Kakkos et al. Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials’

, 2014
Stavros K. Kakkos, George Kirkilesis, Ioannis A. Tsolakis   +2 more
openalex   +1 more source

Rivaroxaban versus low-molecular-weight heparins for short- and long-term prognosis in patients with deep vein thrombosis after spontaneous intracranial hemorrhage. [PDF]

J Comp Eff Res
Li J, Song Q, Zhang G, Tong G, Bian C, Zhang H, Zheng H, Wang Y.   +7 more
europepmc   +1 more source

Treatment of portal vein thrombosis with rivaroxaban in an American cocker spaniel with chronic hepatitis: a case report. [PDF]

J Vet Med Sci
Niijima R, Kakizaki T, Park CH, Kameshima S, Otaka Y, Kawaguchi H.   +5 more
europepmc   +1 more source

OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL

, 2014
Somasekhara R. Balla, Derek D. Cyr, Yuliya Lokhnygina, Richard C. Becker, Scott D. Berkowitz, G Breithardt, Robert M. Califf, Keith A.A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Kenneth W. Mahaffey, Christopher C. Nessel, Jonathan P. Piccini, Daniel E. Singer, Manesh R. Patel   +15 more
openalex   +1 more source

Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction: RIVAWAR, An Open-Label RCT. [PDF]

JACC Adv
Shah JA, Hussain J, Ahmed B, Batra MK, Ali G, Naz M, Khan W, Bhatti KI, Karim M, Hakeem A.   +9 more
europepmc   +1 more source

Safety and effectiveness of Rivaroxaban, Dabigatran and Apixaban in patients with non-valvular atrial fibrillation for stroke prophylaxis. [PDF]

BMC Neurol
Tanoğlu C, Ersoy A.
europepmc   +1 more source

Rapid Screening of Anticoagulation Compounds for Biological Target-Associated Adverse Effects Using a Deep-Learning Framework in the Management of Atrial Fibrillation. [PDF]

Bioengineering (Basel)
Dong T, Llewellyn R, Hezzell M, Angelini GD.   +3 more
europepmc   +1 more source

Assess the reporting quality of randomized controlled clinical trials exploring the efficacy and safety of new anticoagulants versus warfarin in patients with atrial fibrillation based on CONCORT statement [PDF]

, 2016
Μαντζουράτου, Πολυξένη Δ.
core   +1 more source